Allergy Diagnostics and Therapeutics Market by Products (Instruments, Consumables, Services), Allergen Type, Test Type, Drug Class, End-Users, Region, Global Industry Analysis, Market Size, Share, Growth, Trends, and Forecast 2019 to 2026
Published On: July 2019
 
Report ID:396098
 
Category: Healthcare
 
Pages: 250




Global allergy diagnostics and therapeutics market is expected to reach USD 57.31 Billion by 2026 at a CAGR of 6.23% during the forecast period 2019-2026. Rising instances of allergy diseases and growing demand for IVD tests for allergy diagnosis are the two major factors contributing to the growth of the market.

Market Overview:

An allergy is defined as a hypersensitivity disease in the body immune system. Allergy arises when an individual’s immune system reacts to any harmless substances known as allergens. Factors which cause allergy include pet dander, pollen, and dust mite excretion. There are various kinds of allergies such as drug allergy, dust allergy, skin allergy, food allergy, mold allergy and allergy to insect stings. Allergic reactions cause destructive consequences for human wellbeing resulting in huge dreariness due to lung, dermatologic and otolaryngologic issue.

Report Description:                                                                                                                       

  • The base year for the study has been considered 2018, the historic year 2016 and 2017 and, the forecast period considered is from 2019 to 2026. The allergy diagnostics and therapeutics market is analyzed on the basis of value (USD Billion).
  • The study delivers a comprehensive analysis of global allergy diagnostics and therapeutics market by products, allergen type, test type, drug class, end-users, and regions.
  • The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
  • Porter’s Five Forces model is used in order to recognize the competitive scenario in the global allergy diagnostics and therapeutics market. This report incorporates the industry analysis which is focused on providing an extensive view of the allergy diagnostics and therapeutics market.
  • The study also includes attractiveness analysis of products, allergen type, test type, drug class, end-users and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
  • The report provides company profile of the key players operating in the allergy diagnostics and therapeutics market and a comparative analysis based on their business overviews, industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
  • The market estimates have been evaluated by considering the effect of different political, economic, social, technological and legal factors which are based on our extensive secondary research, primary research, and in-house databases.

Market Dynamics:

Drivers:

  • Rising instances of allergy diseases
  • Growing demand for IVD tests for allergy diagnosis
  • Evolution of technologically advanced allergy diagnostics products
  • Rising healthcare expenditure triggering the development of effective allergy diagnostic & therapeutic products.

Restraints:

  • Low adoption and penetration in developing countries due to the high cost of technology
  • Presence of ambiguous regulatory framework

Opportunities:

  • Growing demand from emerging market.

Challenges:

  • Severe government regulation
  • High capital requirements
  • Lack of awareness

Global Allergy Diagnostics and Therapeutics Market Key Findings:

All the segments have been analysed on global, regional and country basis. The study includes the analysis of more than 30 countries for each segment.

Segmentation Analysis:

The allergy diagnostics and therapeutics market is segmented on the basis of products, allergen type, test type, drug class, and end-users.

  • The products segment is classified into instruments, consumables, and services. The consumables segment has dominated the market by holding the highest market share of 52.84% in 2018 as they are an indispensable element in allergy detection.
  • The allergen type segment includes food, inhaled and drug. The inhaled segment valued around USD 17.97 billion in 2018. Rising instances of respiratory allergies and asthma are responsible for the dominance of inhaled allergen segment. It is due to the growing demand for allergy testing and introduction of specific allergen for the detection of allergy.
  • The test type segment is divided into segments such as in vivo and in vitro. In vivo segment is anticipated to grow with the highest CAGR of 7.18% over the forecast period owing to related benefits such as ease of use, time efficiency, wider availability and sensitivity for clinically valid allergies.
  • The drug class segment includes antihistamines, corticosteroids, mast cell stabilizers, leukotriene inhibitors, nasal anticholinergics, decongestants, immunomodulators, auto-injectable epinephrine, and immunotherapy. The antihistamines segment dominated the market with the highest market share of 34.19% in 2018 due to associated benefits with its usage and wide applications in the treatment of allergy diseases.
  • The end-users segment includes academic research institutes, hospitals, and diagnostic laboratories. The hospitals and diagnostic laboratories segment is anticipated to hold the highest share of 38.48% in 2026 due to the increasing use of immunoassay tests in allergy diagnosis coupled with improvements in screening techniques which would enable accurate disease diagnosis and stratification for appropriate treatment.

Regional Segmentation Analysis:                                                                                           

The regions analysed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. North America region dominated the global allergy diagnostics and therapeutics market with USD 12.99 billion in 2018 where as the Asia Pacific region is growing at the faster rate.

  • North America is dominating the market due to the rising number of cases of allergic respiratory disorders and the growing awareness regarding allergy diagnostics coupled with the increasing acceptance of in-vitro blood tests in the region.
  • Asia Pacific region is growing rapidly in the market. It is due to the presence of high unmet needs, improvising healthcare infrastructure and demand for minimally invasive diagnostic tools from the consumer end.

Global Allergy Diagnostics and Therapeutics Market Competitive Analysis:

Key players in the allergy diagnostics and therapeutics market are bioMerieux, Thermo Fisher Scientific, Danaher Corporation, Omega Diagnostics, Hitachi Chemical Diagnostics, Stallergenes Greer, Siemens Healthcare, Lincoln Diagnostics, Hycor Biomedical, HOB Biotech Group and Alcon Laboratories. For instance, in July 2015, Thermo Fisher launched the Phadia 2500E Laboratory System. This product offers better diagnostic solutions by detecting and quantifying the relevant antibodies in blood samples of the patients to identify the possible allergy or autoimmune sensitivity.

*All our reports are customizable as per customer requirements

This study forecasts revenue growth and volume at global, regional, and country levels from 2016 to 2026. Fior Market Research has segmented the global allergy diagnostics and therapeutics market on the basis of below-mentioned segments:

Global Allergy Diagnostics and Therapeutics Market, By Products:

  • Instruments
  • Consumables
  • Services

 Global Allergy Diagnostics and Therapeutics Market, By Allergen Type:

  • Food
  • Inhaled
  • Drug

 Global Allergy Diagnostics and Therapeutics Market, By Test type:

  • In Vivo
  • In Vitro

 Global Allergy Diagnostics and Therapeutics Market, By Drug class:

  • Antihistamines
  • Corticosteroids
  • Mast Cell Stabilizers
  • Leukotriene Inhibitors
  • Nasal Anticholinergics
  • Decongestants
  • Immunomodulators
  • Autoinjectable Epinephrine
  • Immunotherapy

 Global Allergy Diagnostics and Therapeutics Market, By End-Users:

  • Academic Research Institutes
  • Hospitals
  • Diagnostic Laboratories

 Global Allergy Diagnostics and Therapeutics Market, By Regions:

  • North America
  • U.S.
  • Canada
  • Mexico
  • Europe
  • Germany
  • France
  • U.K.
  • Italy
  • Spain
  • Asia-Pacific
  • Japan
  • China
  • India
  • South America
  • Brazil
  • Middle East and Africa         
  • UAE
  • South Africa
  1. INTRODUCTION
    1. OBJECTIVES OF THE STUDY
    2. MARKET DEFINITION
    3. RESEARCH SCOPE
    4. CURRENCY
  2. RESEARCH METHODOLOGY AND ASSUMPTIONS
  3. EXECUTIVE SUMMARY
  4. PREMIUM INSIGHTS
    1. TOP INVESTMENT POCKETS
      1. MARKET ATTRACTIVENESS ANALYSIS BY PRODUCTS
      2. MARKET ATTRACTIVENESS ANALYSIS BY ALLERGEN TYPE
      3. MARKET ATTRACTIVENESS ANALYSIS BY TEST TYPE
      4. MARKET ATTRACTIVENESS ANALYSIS BY DRUG CLASS
      5. MARKET ATTRACTIVENESS ANALYSIS BY END-USERS
      6. MARKET ATTRACTIVENESS ANALYSIS BY REGION
    2. PORTER’S FIVE FORCES ANALYSIS
      1. THREAT OF NEW ENTRANTS
      2. THREAT OF SUBSTITUTES
      3. BARGAINING POWER OF SUPPLIERS
      4. BARGAINING POWER OF BUYERS
      5. INTENSITY OF COMPETITIVE RIVALRY
    3. PESTEL ANALYSIS
    4. INDUSTRY SWOT ANALYSIS
    5. INDUSTRY TRENDS
    6. MICRO AND MACRO FACTORS AFFECTING GLOBAL ALLERGY DIAGNOSTICS AND THERAPEUTICS 
    7. CUSTOMERS/BUYERS BY REGIONS
  5. MARKET DYNAMICS
    1. MARKET EVALUATION
    2. DRIVERS
      1. RISING INSTANCES OF ALLERGY DISEASES
      2. GROWING DEMAND FOR IVD TESTS FOR ALLERGY DIAGNOSIS
      3. EVOLUTION OF TECHNOLOGICALLY ADVANCED ALLERGY DIAGNOSTICS PRODUCTS
      4. RISING HEALTHCARE EXPENDITURE TRIGGERING DEVELOPMENT OF EFFECTIVE ALLERGY DIAGNOSTIC & THERAPEUTIC PRODUCTS.
    3. RESTRAINTS
      1. LOW ADOPTION AND PENETRATION IN DEVELOPING COUNTRIES DUE TO HIGH COST OF TECHNOLOGY
      2. PRESENCE OF AMBIGUOUS REGULATORY FRAMEWORK
    4. OPPORTUNITIES
      1. GROWING DEMAND FROM EMERGING MARKET
    5. CHALLENGES
      1. SEVERE GOVERNMENT REGULATION
      2. HIGH CAPITAL REQUIREMENTS
      3. LACK OF AWARENESS
  6. GLOBAL ALLERGY DIAGNOSTICS AND THERAPEUTICS  MARKET ANALYSIS AND FORECAST, BY PRODUCTS
    1. SEGMENT OVERVIEW
    2. INSTRUMENTS
    3. CONSUMABLES
    4. SERVICES
  7. GLOBAL ALLERGY DIAGNOSTICS AND THERAPEUTICS  MARKET ANALYSIS AND FORECAST, BY ALLERGEN TYPE
    1. SEGMENT OVERVIEW
    2. FOOD
    3. INHALED
    4. DRUG
  8. GLOBAL ALLERGY DIAGNOSTICS AND THERAPEUTICS  MARKET ANALYSIS AND FORECAST, BY DRUG CLASS
    1. SEGMENT OVERVIEW
    2. ANTIHISTAMINES
    3. CORTICOSTEROIDS
    4. MAST CELL STABILIZERS
    5. LEUKOTRIENE INHIBITORS
    6. NASAL ANTICHOLINERGICS
    7. DECONGESTANTS
    8. IMMUNOMODULATORS
    9. AUTOINJECTABLE EPINEPHRINE
    10. IMMUNOTHERAPY
  9.  GLOBAL ALLERGY DIAGNOSTICS AND THERAPEUTICS  MARKET ANALYSIS AND FORECAST, BY TEST TYPE
    1. SEGMENT OVERVIEW
    2. IN VIVO
    3. IN VITRO
  10. GLOBAL ALLERGY DIAGNOSTICS AND THERAPEUTICS  MARKET ANALYSIS AND FORECAST, BY END-USERS
    1. SEGMENT OVERVIEW
    2. ACADEMIC RESEARCH INSTITUTES
    3. HOSPITALS
    4. DIAGNOSTIC LABORATORIES
  11. GLOBAL ALLERGY DIAGNOSTICS AND THERAPEUTICS  MARKET ANALYSIS AND FORECAST, BY REGIONAL ANALYSIS
    1. SEGMENT OVERVIEW
    2. NORTH AMERICA
      1. U.S.
      2. CANADA
      3. MEXICO
    3. EUROPE
      1. GERMANY
      2. FRANCE
      3. U.K.
      4. ITALY
      5. SPAIN
      6. REST OF EUROPE
    4. ASIA-PACIFIC
      1. JAPAN
      2. CHINA
      3. INDIA
      4. REST OF APAC
    5. SOUTH AMERICA
      1. BRAZIL
      2. REST OF SA
    6. MIDDLE EAST AND AFRICA
      1. UAE
      2. SOUTH AFRICA
      3. REST OF MEA
  12. GLOBAL ALLERGY DIAGNOSTICS AND THERAPEUTICS  MARKET-COMPETITIVE LANDSCAPE
    1. OVERVIEW
    2. MARKET SHARE OF KEY PLAYERS IN THE ALLERGY DIAGNOSTICS AND THERAPEUTICS  MARKET
      1. GLOBAL COMPANY MARKET SHARE
      2. NORTH AMERICA COMPANY MARKET SHARE
      3. EUROPE COMPANY MARKET SHARE
      4. APAC COMPANY MARKET SHARE
    3. COMPETITIVE SITUATIONS AND TRENDS
      1. PRODUCT LAUNCHES AND DEVELOPMENTS
      2. PARTNERSHIPS, COLLABORATIONS, AND AGREEMENTS
      3. MERGERS & ACQUISITIONS
      4. EXPANSIONS
  13. COMPANY PROFILES
    1. BIOMERIEUX
      1. BUSINESS OVERVIEW
      2. COMPANY SNAPSHOT
      3. KEY FINANCIAL
        1. REVENUE ANALYSIS
        2. MARGIN ANALYSIS
        3. COMPANY SEGMENT ANALYSIS
      4. COMPANY PRODUCT PORTFOLIO
      5. RECENT DEVELOPMENTS
      6. SWOT ANALYSIS
    2. THERMO FISHER SCIENTIFIC
    3. DANAHER CORPORATION
    4. OMEGA DIAGNOSTICS
    5. HITACHI CHEMICAL DIAGNOSTICS
    6. STALLERGENES GREER
    7. SIEMENS HEALTHCARE
    8. LINCOLN DIAGNOSTICS
    9. HYCOR BIOMEDICAL
    10. HOB BIOTECH GROUP
    11. ALCON LABORATORIES

LIST OF TABLE

  1. GLOBAL ALLERGY DIAGNOSTICS AND THERAPEUTICS  MARKET, BY PRODUCTS, 2016–2026 REVENUE (USD MILLION)
  2. GLOBAL INSTRUMENTS ALLERGY DIAGNOSTICS AND THERAPEUTICS  MARKET, BY REGION, 2016–2026 REVENUE(USD MILLION)
  3. GLOBAL CONSUMABLES ALLERGY DIAGNOSTICS AND THERAPEUTICS  MARKET, BY REGION, 2016–2026 REVENUE(USD MILLION)
  4. GLOBAL SERVICES ALLERGY DIAGNOSTICS AND THERAPEUTICS  MARKET, BY REGION, 2016–2026 REVENUE(USD MILLION)
  5. GLOBAL ALLERGY DIAGNOSTICS AND THERAPEUTICS  MARKET, BY ALLERGEN TYPE, 2016–2026 REVENUE(USD MILLION)
  6. GLOBAL FOOD ALLERGY DIAGNOSTICS AND THERAPEUTICS  MARKET, BY REGION, 2016–2026 REVENUE(USD MILLION)
  7. GLOBAL INHALED ALLERGY DIAGNOSTICS AND THERAPEUTICS  MARKET, BY REGION, 2016–2026 REVENUE(USD MILLION)
  8. GLOBAL DRUG ALLERGY DIAGNOSTICS AND THERAPEUTICS  MARKET, BY REGION, 2016–2026 REVENUE(USD MILLION)
  9. GLOBAL ALLERGY DIAGNOSTICS AND THERAPEUTICS MARKET, BY TEST TYPE, 2016–2026 REVENUE(USD MILLION)
  10. GLOBAL IN VIVO ALLERGY DIAGNOSTICS AND THERAPEUTICS  MARKET, BY REGION, 2016–2026 REVENUE(USD MILLION)
  11. GLOBAL IN VITRO ALLERGY DIAGNOSTICS AND THERAPEUTICS  MARKET, BY REGION, 2016–2026 REVENUE(USD MILLION)
  12. GLOBAL ALLERGY DIAGNOSTICS AND THERAPEUTICS MARKET, BY DRUG CLASS, 2016–2026 REVENUE(USD MILLION)
  13. GLOBAL ANTIHISTAMINES ALLERGY DIAGNOSTICS AND THERAPEUTICS  MARKET, BY REGION, 2016–2026 REVENUE(USD MILLION)
  14. GLOBAL CORTICOSTEROIDS ALLERGY DIAGNOSTICS AND THERAPEUTICS  MARKET, BY REGION, 2016–2026 REVENUE(USD MILLION)
  15. GLOBAL MAST CELL STABILIZERS ALLERGY DIAGNOSTICS AND THERAPEUTICS  MARKET, BY REGION, 2016–2026 REVENUE(USD MILLION)
  16. GLOBAL LEUKOTRIENE INHIBITORS ALLERGY DIAGNOSTICS AND THERAPEUTICS  MARKET, BY REGION, 2016–2026 REVENUE(USD MILLION)
  17. GLOBAL NASAL ANTICHOLINERGICS ALLERGY DIAGNOSTICS AND THERAPEUTICS  MARKET, BY REGION, 2016–2026 REVENUE(USD MILLION)
  18. GLOBAL DECONGESTANTS ALLERGY DIAGNOSTICS AND THERAPEUTICS  MARKET, BY REGION, 2016–2026 REVENUE(USD MILLION)
  19. GLOBAL IMMUNOMODULATORS ALLERGY DIAGNOSTICS AND THERAPEUTICS  MARKET, BY REGION, 2016–2026 REVENUE(USD MILLION)
  20. GLOBAL AUTOINJECTABLE EPINEPHRINE ALLERGY DIAGNOSTICS AND THERAPEUTICS  MARKET, BY REGION, 2016–2026 REVENUE(USD MILLION)
  21. GLOBAL IMMUNOTHERAPY ALLERGY DIAGNOSTICS AND THERAPEUTICS  MARKET, BY REGION, 2016–2026 REVENUE(USD MILLION)
  22. GLOBAL ALLERGY DIAGNOSTICS AND THERAPEUTICS  MARKET, BY END-USERS, 2016–2026 REVENUE(USD MILLION)
  23. GLOBAL ACADEMIC RESEARCH INSTITUTES ALLERGY DIAGNOSTICS AND THERAPEUTICS  MARKET, BY REGION, 2016–2026 REVENUE(USD MILLION)
  24. GLOBAL HOSPITALS ALLERGY DIAGNOSTICS AND THERAPEUTICS  MARKET, BY REGION, 2016–2026 REVENUE(USD MILLION)
  25. GLOBAL DIAGNOSTIC LABORATORIES ALLERGY DIAGNOSTICS AND THERAPEUTICS  MARKET, BY REGION, 2016–2026 REVENUE(USD MILLION)
  26. GLOBAL ALLERGY DIAGNOSTICS AND THERAPEUTICS  MARKET, BY REGION, 2016–2026 REVENUE(USD MILLION)
  27. NORTH AMERICA ALLERGY DIAGNOSTICS AND THERAPEUTICS  MARKET, BY PRODUCTS, 2016–2026 REVENUE(USD MILLION)
  28. NORTH AMERICA ALLERGY DIAGNOSTICS AND THERAPEUTICS  MARKET, BY ALLERGEN TYPE, 2016–2026 REVENUE(USD MILLION)
  29. NORTH AMERICA ALLERGY DIAGNOSTICS AND THERAPEUTICS  MARKET, BY TEST TYPE, 2016–2026 REVENUE(USD MILLION)
  30. NORTH AMERICA ALLERGY DIAGNOSTICS AND THERAPEUTICS  MARKET, BY DRUG CLASS, 2016–2026 REVENUE(USD MILLION)
  31. NORTH AMERICA ALLERGY DIAGNOSTICS AND THERAPEUTICS  MARKET, BY END-USERS, 2016–2026 REVENUE(USD MILLION)
  32. U.S. ALLERGY DIAGNOSTICS AND THERAPEUTICS  MARKET, BY PRODUCTS, 2016–2026 REVENUE(USD MILLION)
  33. U.S. ALLERGY DIAGNOSTICS AND THERAPEUTICS  MARKET, BY ALLERGEN TYPE, 2016–2026 REVENUE(USD MILLION)
  34. U.S. ALLERGY DIAGNOSTICS AND THERAPEUTICS  MARKET, BY TEST TYPE, 2016–2026 REVENUE(USD MILLION)
  35. U.S. ALLERGY DIAGNOSTICS AND THERAPEUTICS  MARKET, BY DRUG CLASS, 2016–2026 REVENUE(USD MILLION)
  36. U.S ALLERGY DIAGNOSTICS AND THERAPEUTICS  MARKET, BY END-USERS, 2016–2026 REVENUE(USD MILLION)
  37. CANADA ALLERGY DIAGNOSTICS AND THERAPEUTICS  MARKET, BY PRODUCTS, 2016–2026 REVENUE(USD MILLION)
  38. CANADA ALLERGY DIAGNOSTICS AND THERAPEUTICS  MARKET, BY ALLERGEN TYPE, 2016–2026 REVENUE(USD MILLION)
  39. CANADA ALLERGY DIAGNOSTICS AND THERAPEUTICS  MARKET, BY TEST TYPE, 2016–2026 REVENUE(USD MILLION)
  40. CANADA ALLERGY DIAGNOSTICS AND THERAPEUTICS  MARKET, BY DRUG CLASS, 2016–2026 REVENUE(USD MILLION)
  41. CANADA ALLERGY DIAGNOSTICS AND THERAPEUTICS  MARKET, BY END-USERS, 2016–2026 REVENUE(USD MILLION)
  42. MEXICO ALLERGY DIAGNOSTICS AND THERAPEUTICS  MARKET, BY PRODUCTS, 2016–2026 REVENUE(USD MILLION)
  43. MEXICO ALLERGY DIAGNOSTICS AND THERAPEUTICS  MARKET, BY ALLERGEN TYPE, 2016–2026 REVENUE(USD MILLION)
  44. MEXICO ALLERGY DIAGNOSTICS AND THERAPEUTICS  MARKET, BY TEST TYPE, 2016–2026 REVENUE(USD MILLION)
  45. MEXICO ALLERGY DIAGNOSTICS AND THERAPEUTICS  MARKET, BY DRUG CLASS, 2016–2026 REVENUE(USD MILLION)
  46. MEXICO ALLERGY DIAGNOSTICS AND THERAPEUTICS  MARKET, BY END-USERS, 2016–2026 REVENUE(USD MILLION)
  47. EUROPE ALLERGY DIAGNOSTICS AND THERAPEUTICS  MARKET, BY PRODUCTS, 2016–2026 REVENUE(USD MILLION)
  48. EUROPE ALLERGY DIAGNOSTICS AND THERAPEUTICS  MARKET, BY ALLERGEN TYPE, 2016–2026 REVENUE(USD MILLION)
  49. EUROPE ALLERGY DIAGNOSTICS AND THERAPEUTICS  MARKET, BY TEST TYPE, 2016–2026 REVENUE(USD MILLION)
  50. EUROPE ALLERGY DIAGNOSTICS AND THERAPEUTICS  MARKET, BY DRUG CLASS, 2016–2026 REVENUE(USD MILLION)
  51. EUROPE ALLERGY DIAGNOSTICS AND THERAPEUTICS  MARKET, BY END-USERS, 2016–2026 REVENUE(USD MILLION)
  52. EUROPE ALLERGY DIAGNOSTICS AND THERAPEUTICS  MARKET, BY INDUSTRY VERTICAL, 2016–2026 REVENUE(USD MILLION)
  53. GERMANY ALLERGY DIAGNOSTICS AND THERAPEUTICS  MARKET, BY PRODUCTS, 2016–2026 REVENUE(USD MILLION)
  54. GERMANY ALLERGY DIAGNOSTICS AND THERAPEUTICS  MARKET, BY ALLERGEN TYPE, 2016–2026 REVENUE(USD MILLION)
  55. GERMANY ALLERGY DIAGNOSTICS AND THERAPEUTICS  MARKET, BY TEST TYPE, 2016–2026 REVENUE(USD MILLION)
  56. GERMANY ALLERGY DIAGNOSTICS AND THERAPEUTICS  MARKET, BY DRUG CLASS, 2016–2026 REVENUE(USD MILLION)
  57. GERMANY ALLERGY DIAGNOSTICS AND THERAPEUTICS  MARKET, BY END-USERS, 2016–2026 REVENUE(USD MILLION)
  58. FRANCE ALLERGY DIAGNOSTICS AND THERAPEUTICS  MARKET, BY PRODUCTS, 2016–2026 REVENUE(USD MILLION)
  59. FRANCE ALLERGY DIAGNOSTICS AND THERAPEUTICS  MARKET, BY ALLERGEN TYPE, 2016–2026 REVENUE(USD MILLION)
  60. FRANCE ALLERGY DIAGNOSTICS AND THERAPEUTICS  MARKET, BY TEST TYPE, 2016–2026 REVENUE(USD MILLION)
  61. FRANCE ALLERGY DIAGNOSTICS AND THERAPEUTICS  MARKET, BY DRUG CLASS, 2016–2026 REVENUE(USD MILLION)
  62. FRANCE ALLERGY DIAGNOSTICS AND THERAPEUTICS  MARKET, BY END-USERS, 2016–2026 REVENUE(USD MILLION)
  63. U.K. ALLERGY DIAGNOSTICS AND THERAPEUTICS  MARKET, BY PRODUCTS, 2016–2026 REVENUE(USD MILLION)
  64. U.K. ALLERGY DIAGNOSTICS AND THERAPEUTICS  MARKET, BY ALLERGEN TYPE, 2016–2026 REVENUE(USD MILLION)
  65. U.K. ALLERGY DIAGNOSTICS AND THERAPEUTICS  MARKET, BY TEST TYPE, 2016–2026 REVENUE(USD MILLION)
  66. U.K. ALLERGY DIAGNOSTICS AND THERAPEUTICS  MARKET, BY DRUG CLASS, 2016–2026 REVENUE(USD MILLION)
  67. U.K. ALLERGY DIAGNOSTICS AND THERAPEUTICS  MARKET, BY END-USERS, 2016–2026 REVENUE(USD MILLION)
  68. ITALY ALLERGY DIAGNOSTICS AND THERAPEUTICS  MARKET, BY PRODUCTS, 2016–2026 REVENUE(USD MILLION)
  69. ITALY ALLERGY DIAGNOSTICS AND THERAPEUTICS  MARKET, BY ALLERGEN TYPE, 2016–2026 REVENUE(USD MILLION)
  70. ITALY ALLERGY DIAGNOSTICS AND THERAPEUTICS  MARKET, BY TEST TYPE, 2016–2026 REVENUE(USD MILLION)
  71. ITALY ALLERGY DIAGNOSTICS AND THERAPEUTICS  MARKET, BY DRUG CLASS, 2016–2026 REVENUE(USD MILLION)
  72. ITALY ALLERGY DIAGNOSTICS AND THERAPEUTICS  MARKET, BY END-USERS, 2016–2026 REVENUE(USD MILLION)
  73. SPAIN ALLERGY DIAGNOSTICS AND THERAPEUTICS  MARKET, BY PRODUCTS, 2016–2026 REVENUE(USD MILLION)
  74. SPAIN ALLERGY DIAGNOSTICS AND THERAPEUTICS  MARKET, BY ALLERGEN TYPE, 2016–2026 REVENUE(USD MILLION)
  75. SPAIN ALLERGY DIAGNOSTICS AND THERAPEUTICS  MARKET, BY TEST TYPE, 2016–2026 REVENUE(USD MILLION)
  76. SPAIN ALLERGY DIAGNOSTICS AND THERAPEUTICS  MARKET, BY DRUG CLASS, 2016–2026 REVENUE(USD MILLION)
  77. SPAIN ALLERGY DIAGNOSTICS AND THERAPEUTICS  MARKET, BY END-USERS, 2016–2026 REVENUE(USD MILLION)
  78. ASIA PACIFIC ALLERGY DIAGNOSTICS AND THERAPEUTICS  MARKET, BY PRODUCTS, 2016–2026 REVENUE(USD MILLION)
  79. ASIA PACIFIC ALLERGY DIAGNOSTICS AND THERAPEUTICS  MARKET, BY ALLERGEN TYPE, 2016–2026 REVENUE(USD MILLION)
  80. ASIA PACIFIC ALLERGY DIAGNOSTICS AND THERAPEUTICS  MARKET, BY TEST TYPE, 2016–2026 REVENUE(USD MILLION)
  81. ASIA PACIFIC ALLERGY DIAGNOSTICS AND THERAPEUTICS  MARKET, BY DRUG CLASS, 2016–2026 REVENUE(USD MILLION)
  82. ASIA PACIFIC ALLERGY DIAGNOSTICS AND THERAPEUTICS  MARKET, BY END-USERS, 2016–2026 REVENUE(USD MILLION)
  83. JAPAN ALLERGY DIAGNOSTICS AND THERAPEUTICS  MARKET, BY PRODUCTS, 2016–2026 REVENUE(USD MILLION)
  84. JAPAN ALLERGY DIAGNOSTICS AND THERAPEUTICS  MARKET, BY ALLERGEN TYPE, 2016–2026 REVENUE(USD MILLION)
  85. JAPAN ALLERGY DIAGNOSTICS AND THERAPEUTICS  MARKET, BY TEST TYPE, 2016–2026 REVENUE(USD MILLION)
  86. JAPAN ALLERGY DIAGNOSTICS AND THERAPEUTICS  MARKET, BY DRUG CLASS, 2016–2026 REVENUE(USD MILLION)
  87. JAPAN ALLERGY DIAGNOSTICS AND THERAPEUTICS  MARKET, BY END-USERS, 2016–2026 REVENUE(USD MILLION)
  88. CHINA ALLERGY DIAGNOSTICS AND THERAPEUTICS  MARKET, BY PRODUCTS, 2016–2026 REVENUE(USD MILLION)
  89. CHINA ALLERGY DIAGNOSTICS AND THERAPEUTICS  MARKET, BY ALLERGEN TYPE, 2016–2026 REVENUE(USD MILLION)
  90. CHINA ALLERGY DIAGNOSTICS AND THERAPEUTICS  MARKET, BY TEST TYPE, 2016–2026 REVENUE(USD MILLION)
  91. CHINA ALLERGY DIAGNOSTICS AND THERAPEUTICS  MARKET, BY DRUG CLASS, 2016–2026 REVENUE(USD MILLION)
  92. CHINA ALLERGY DIAGNOSTICS AND THERAPEUTICS  MARKET, BY END-USERS, 2016–2026 REVENUE(USD MILLION)
  93. INDIA ALLERGY DIAGNOSTICS AND THERAPEUTICS  MARKET, BY PRODUCTS, 2016–2026 REVENUE(USD MILLION)
  94. INDIA ALLERGY DIAGNOSTICS AND THERAPEUTICS  MARKET, BY ALLERGEN TYPE, 2016–2026 REVENUE(USD MILLION)
  95. INDIA ALLERGY DIAGNOSTICS AND THERAPEUTICS  MARKET, BY TEST TYPE, 2016–2026 REVENUE(USD MILLION)
  96. INDIA ALLERGY DIAGNOSTICS AND THERAPEUTICS  MARKET, BY DRUG CLASS, 2016–2026 REVENUE(USD MILLION)
  97. INDIA ALLERGY DIAGNOSTICS AND THERAPEUTICS  MARKET, BY END-USERS, 2016–2026 REVENUE(USD MILLION)
  98. SOUTH AMERICA ALLERGY DIAGNOSTICS AND THERAPEUTICS  MARKET, BY PRODUCTS, 2016–2026 REVENUE(USD MILLION)
  99. SOUTH AMERICA ALLERGY DIAGNOSTICS AND THERAPEUTICS  MARKET, BY ALLERGEN TYPE, 2016–2026 REVENUE(USD MILLION)
  100. SOUTH AMERICA ALLERGY DIAGNOSTICS AND THERAPEUTICS  MARKET, BY TEST TYPE, 2016–2026 REVENUE(USD MILLION)
  101. SOUTH AMERICA ALLERGY DIAGNOSTICS AND THERAPEUTICS  MARKET, BY DRUG CLASS, 2016–2026 REVENUE(USD MILLION)
  102. SOUTH AMERICA ALLERGY DIAGNOSTICS AND THERAPEUTICS  MARKET, BY END-USERS, 2016–2026 REVENUE(USD MILLION)
  103. BRAZIL ALLERGY DIAGNOSTICS AND THERAPEUTICS  MARKET, BY PRODUCTS, 2016–2026 REVENUE(USD MILLION)
  104. BRAZIL ALLERGY DIAGNOSTICS AND THERAPEUTICS  MARKET, BY ALLERGEN TYPE, 2016–2026 REVENUE(USD MILLION)
  105. BRAZIL ALLERGY DIAGNOSTICS AND THERAPEUTICS  MARKET, BY TEST TYPE, 2016–2026 REVENUE(USD MILLION)
  106. BRAZIL ALLERGY DIAGNOSTICS AND THERAPEUTICS  MARKET, BY DRUG CLASS, 2016–2026 REVENUE(USD MILLION)
  107. BRAZIL ALLERGY DIAGNOSTICS AND THERAPEUTICS  MARKET, BY END-USERS, 2016–2026 REVENUE(USD MILLION)
  108. MIDDLE EAST AND AFRICA ALLERGY DIAGNOSTICS AND THERAPEUTICS  MARKET, BY PRODUCTS, 2016–2026 REVENUE(USD MILLION)
  109. MIDDLE EAST AND AFRICA ALLERGY DIAGNOSTICS AND THERAPEUTICS  MARKET, BY ALLERGEN TYPE, 2016–2026 REVENUE(USD MILLION)
  110. MIDDLE EAST AND AFRICA ALLERGY DIAGNOSTICS AND THERAPEUTICS  MARKET, BY TEST TYPE, 2016–2026 REVENUE(USD MILLION)
  111. MIDDLE EAST AND AFRICA ALLERGY DIAGNOSTICS AND THERAPEUTICS  MARKET, BY DRUG CLASS, 2016–2026 REVENUE(USD MILLION)
  112. MIDDLE EAST AND AFRICA ALLERGY DIAGNOSTICS AND THERAPEUTICS  MARKET, BY END-USERS, 2016–2026 REVENUE(USD MILLION)
  113. UAE ALLERGY DIAGNOSTICS AND THERAPEUTICS  MARKET, BY PRODUCTS, 2016–2026 REVENUE(USD MILLION)
  114. UAE ALLERGY DIAGNOSTICS AND THERAPEUTICS  MARKET, BY ALLERGEN TYPE, 2016–2026 REVENUE(USD MILLION)
  115. UAE ALLERGY DIAGNOSTICS AND THERAPEUTICS  MARKET, BY TEST TYPE, 2016–2026 REVENUE(USD MILLION)
  116. UAE ALLERGY DIAGNOSTICS AND THERAPEUTICS  MARKET, BY DRUG CLASS, 2016–2026 REVENUE(USD MILLION)
  117. UAE ALLERGY DIAGNOSTICS AND THERAPEUTICS  MARKET, BY END-USERS, 2016–2026 REVENUE(USD MILLION)
  118. SOUTH AFRICA ALLERGY DIAGNOSTICS AND THERAPEUTICS  MARKET, BY PRODUCTS, 2016–2026 REVENUE(USD MILLION)
  119. SOUTH AFRICA ALLERGY DIAGNOSTICS AND THERAPEUTICS  MARKET, BY ALLERGEN TYPE, 2016–2026 REVENUE(USD MILLION)
  120. SOUTH AFRICA ALLERGY DIAGNOSTICS AND THERAPEUTICS  MARKET, BY TEST TYPE, 2016–2026 REVENUE(USD MILLION)
  121. SOUTH AFRICA ALLERGY DIAGNOSTICS AND THERAPEUTICS  MARKET, BY DRUG CLASS, 2016–2026 REVENUE(USD MILLION)
  122. SOUTH AFRICA ALLERGY DIAGNOSTICS AND THERAPEUTICS  MARKET, BY END-USERS, 2016–2026 REVENUE(USD MILLION)

LIST OF FIGURES 

  1. GLOBAL ALLERGY DIAGNOSTICS AND THERAPEUTICS  MARKET SEGMENTATION
  2. ALLERGY DIAGNOSTICS AND THERAPEUTICS  MARKET: RESEARCH METHODOLOGY
  3. MARKET SIZE ESTIMATION METHODOLOGY: BOTTOM-UP APPROACH
  4. MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH
  5. DATA TRIANGULATION
  6. PORTER’S FIVE FORCES ANALYSIS
  7. VALUE CHAIN ANALYSIS
  8. GLOBAL ALLERGY DIAGNOSTICS AND THERAPEUTICS  MARKET ATTRACTIVENESS ANALYSIS BY PRODUCTS
  9. GLOBAL ALLERGY DIAGNOSTICS AND THERAPEUTICS  MARKET ATTRACTIVENESS ANALYSIS BY ALLERGEN TYPE
  10. GLOBAL ALLERGY DIAGNOSTICS AND THERAPEUTICS  MARKET ATTRACTIVENESS ANALYSIS BY TEST TYPE
  11. GLOBAL ALLERGY DIAGNOSTICS AND THERAPEUTICS  MARKET ATTRACTIVENESS ANALYSIS BY DRUG CLASS
  12. GLOBAL ALLERGY DIAGNOSTICS AND THERAPEUTICS  MARKET ATTRACTIVENESS ANALYSIS BY END-USERS
  13. GLOBAL ALLERGY DIAGNOSTICS AND THERAPEUTICS  MARKET ATTRACTIVENESS ANALYSIS BY REGION
  14. GLOBAL ALLERGY DIAGNOSTICS AND THERAPEUTICS  MARKET: DYNAMICS
  15. GLOBAL ALLERGY DIAGNOSTICS AND THERAPEUTICS  MARKET SHARE BY PRODUCTS (2018 & 2026)
  16. GLOBAL ALLERGY DIAGNOSTICS AND THERAPEUTICS  MARKET SHARE BY ALLERGEN TYPE (2018 & 2026)
  17. GLOBAL ALLERGY DIAGNOSTICS AND THERAPEUTICS  MARKET SHARE BY TEST TYPE (2018 & 2026)
  18. GLOBAL ALLERGY DIAGNOSTICS AND THERAPEUTICS  MARKET SHARE BY DRUG CLASS (2018 & 2026)
  19. GLOBAL ALLERGY DIAGNOSTICS AND THERAPEUTICS  MARKET SHARE BY APPLICATION (2018 & 2026)
  20. GLOBAL ALLERGY DIAGNOSTICS AND THERAPEUTICS  MARKET SHARE BY END-USERS (2018 & 2026)
  21. GLOBAL ALLERGY DIAGNOSTICS AND THERAPEUTICS  MARKET SHARE BY REGIONS (2018 & 2026)
  22. GLOBAL ALLERGY DIAGNOSTICS AND THERAPEUTICS  MARKET SHARE BY COMPANY (2018)

EXTRA CUSTOMIZATION

  • NORTH AMERICA
    • U.S.
    • CANADA
    • MEXICO
  • EUROPE
    • GERMANY
    • FRANCE
    • SWEDEN
    • NETHERLANDS
    • U.K.
    • ITALY
    • SPAIN
    • TURKEY
    • SWITZERLAND
    • BELGIUM
    • REST OF EUROPE
  • ASIA-PACIFIC
    • JAPAN
    • CHINA
    • INDIA
    • SOUTH KOREA
    • AUSTRALIA
    • SINGAPORE
    • MALAYSIA
    • THAILAND
    • INDONESIA
    • PHILIPPINES
    • REST OF ASIA PACIFIC
  • SOUTH AMERICA
    • BRAZIL
    • ARGENTINA
    • COLOMBIA
    • REST OF SOUTH AMERICA
  • MIDDLE EAST AND AFRICA
    • SAUDI ARABIA
    • UAE
    • EGYPT
    • NIGERIA
    • SOUTH AFRICA
    • REST OF  MIDDLE EAST AND AFRICA


Please fill the form below, to recieve the report sample

Name*
Email*
Phone*
Name of the Company*
Title / Designation*
Country*
Your specific requirements*
Human Verification*

Please fill the form below for enquiry

Name*
Email*
Phone*
Name of the Company*
Title / Designation*
Country*
Your specific requirements*
Human Verification*
   Our Clients
  • \


Copyright © 2019 Fior Market Research LLP, All Rights Reserved.